Astanand Jugessur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Astanand Jugessur has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Allen James Wilcox
Epidemiology Branch, Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, NC
4 shared publications - Jack A. Taylor
Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health (NIH), Research Triangle Park, Durham, NC 27709, USA
4 shared publications Hallvard A. Vindenes
Department of Plastic Surgery, Haukeland University Hospital, Bergen, Norway
3 shared publicationsJeffrey C. Murray
Department of Pediatrics, University of Iowa, Iowa City, Iowa
3 shared publicationsRolv T. Lie
Section for Medical Statistics and Medical Birth Registry of Norway, University of Bergen, Bergen, Norway
3 shared publicationsFrank E. Åbyholm
Department of Plastic Surgery, Rikshospitalet, Oslo, Norway
2 shared publications
Latest Publications
- 1 February 2011
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 66 (2) , 85-87
Maternal Alcohol Consumption, Alcohol Metabolism Genes, and the Risk of Oral Clefts: A Population-Based Case-Control Study in Norway, 1996–2001
Alcohol is a well-known teratogen, and previous studies have shown that the risk of oral clefts is increased by heavy maternal alcohol consumption—defined as 5 or more alcoholic drinks per sitting—during the first trimester of pregnancy. However, it is unclear whether genetic variation in maternal alcohol metabolism affects its teratogenicity. For consumption of a given level of alcohol, reduced rates of alcohol metabolism in a mother and fetus could increase the time of exposure of the fetus to higher peak levels of alcohol. The alcohol dehydrogenase 1 C (ADH1C) gene has been identified as a risk factor for cleft lip and palate independent of alcohol consumption. Previous reports have suggested that variants in the ADH1C gene may modify the association between alcohol and clefts by changing the rate of alcohol metabolism. This population-based case-control study investigated the association between oral clefts and maternal alcohol consumption among mothers and infants with ADH1C haplotypes encoding slow or fast alcohol metabolizing phenotypes. The study was conducted in Norway between 1996 and 2001; the study group included 483 Norwegian infants born with oral clefts and their mothers, and the control group was comprised of 503 structurally normal infants and their mothers, randomly selected from other live births. The level of alcohol consumption during the first 3 months of pregnancy was assessed with a self-administered, mailed questionnaire. As compared to abstaining from all alcohol use, consumption of 5 or more alcoholic drinks per sitting (binge drinking) during the first trimester of pregnancy was associated with more than twice the risk of having an infant with an oral cleft; the odds ratio (OR) was 2.6, with a 95% confidence interval (CI) of 1.4 to 4.7. This relationship was present only if either the mother or the infant carried the ADH1C variant associated with reduced alcohol metabolism (OR, 3.0; 95% CI, 1.4–6.8). There was no evidence of a relationship between maternal drinking and risk of fetal clefts if both mother and infant had only the rapid metabolism variant (OR, 0.9; 95% CI, 0.2–4.1). These findings demonstrate that the presence of slow-metabolism variants of alcohol-metabolizing genes in either the mother or fetus can substantially increase the risk of oral clefts in babies of mothers who are binge drinkers during the first trimester of pregnancy. Genetic variations in the capacity of the mother to metabolize alcohol may modify the teratogenic effects of maternal alcohol drinking.
- 1 February 2011
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 66 (2) , 85-87
Maternal Alcohol Consumption, Alcohol Metabolism Genes, and the Risk of Oral Clefts: A Population-Based Case-Control Study in Norway, 1996–2001
Alcohol is a well-known teratogen, and previous studies have shown that the risk of oral clefts is increased by heavy maternal alcohol consumption—defined as 5 or more alcoholic drinks per sitting—during the first trimester of pregnancy. However, it is unclear whether genetic variation in maternal alcohol metabolism affects its teratogenicity. For consumption of a given level of alcohol, reduced rates of alcohol metabolism in a mother and fetus could increase the time of exposure of the fetus to higher peak levels of alcohol. The alcohol dehydrogenase 1 C (ADH1C) gene has been identified as a risk factor for cleft lip and palate independent of alcohol consumption. Previous reports have suggested that variants in the ADH1C gene may modify the association between alcohol and clefts by changing the rate of alcohol metabolism. This population-based case-control study investigated the association between oral clefts and maternal alcohol consumption among mothers and infants with ADH1C haplotypes encoding slow or fast alcohol metabolizing phenotypes. The study was conducted in Norway between 1996 and 2001; the study group included 483 Norwegian infants born with oral clefts and their mothers, and the control group was comprised of 503 structurally normal infants and their mothers, randomly selected from other live births. The level of alcohol consumption during the first 3 months of pregnancy was assessed with a self-administered, mailed questionnaire. As compared to abstaining from all alcohol use, consumption of 5 or more alcoholic drinks per sitting (binge drinking) during the first trimester of pregnancy was associated with more than twice the risk of having an infant with an oral cleft; the odds ratio (OR) was 2.6, with a 95% confidence interval (CI) of 1.4 to 4.7. This relationship was present only if either the mother or the infant carried the ADH1C variant associated with reduced alcohol metabolism (OR, 3.0; 95% CI, 1.4–6.8). There was no evidence of a relationship between maternal drinking and risk of fetal clefts if both mother and infant had only the rapid metabolism variant (OR, 0.9; 95% CI, 0.2–4.1). These findings demonstrate that the presence of slow-metabolism variants of alcohol-metabolizing genes in either the mother or fetus can substantially increase the risk of oral clefts in babies of mothers who are binge drinkers during the first trimester of pregnancy. Genetic variations in the capacity of the mother to metabolize alcohol may modify the teratogenic effects of maternal alcohol drinking.
- 18 November 2003
- Published by Wiley in Genetic Epidemiology
- Vol. 25 (4) , 367-374
Cleft palate, transforming growth factor alpha gene variants, and maternal exposures: Assessing gene‐environment interactions in case‐parent triads
We have previously reported a threefold risk of cleft palate only (CPO) among children homozygous for the less common allele A2 at the TaqI marker site of the transforming growth factor alpha gene (TGFA) (Jugessur et al. [2003a] Genet. Epidemiol. 24:230–239). Here we assess possible interaction between the child'sTGFATaqI A2A2 genotype and maternal cigarette smoking, alcohol consumption, use of multivitamins and folic acid. This was done by comparing the strength of genetic associations between strata of exposed and unexposed case‐parent triads. We also looked for possible gene‐gene interaction with the polymorphic variant C677T of the folic acid‐metabolizing geneMTHFR. We analyzed a total of 88 complete CPO triads selected from a population‐based study of orofacial clefts in Norway (May 1996–1998). No evidence of interaction was observed with either smoking or alcohol use. The risk associated with two copies of the A2 allele atTGFATaqI was strong among children whose mothers did not use folic acid (relative risk=4.5, 95% confidence interval=1.3–15.7), and was only marginal among children whose mothers reported using folic acid (RR=1.4, 95% CI=0.2–12.7). Although the interaction between the child's genotypes atTGFATaqI andMTHFR‐C677T was not statistically significant, the effect of theTGFATaqI A2A2 genotype appeared to be stronger among children with either one or two copies of the T‐allele at C677T (RR=4.0, 95% CI=1.1–13.9) compared to children homozygous for the C‐allele (RR=1.7, 95% CI=0.2–15.7). In conclusion, we find little evidence of interaction between the child's genotypes atTGFATaqI and various exposures for cleft palate, with the possible exception of folic acid intake.Genet Epidemiol25:367–374, 2003.
- 18 November 2003
- Published by Wiley in Genetic Epidemiology
- Vol. 25 (4) , 367-374
Cleft palate, transforming growth factor alpha gene variants, and maternal exposures: Assessing gene‐environment interactions in case‐parent triads
We have previously reported a threefold risk of cleft palate only (CPO) among children homozygous for the less common allele A2 at the TaqI marker site of the transforming growth factor alpha gene (TGFA) (Jugessur et al. [2003a] Genet. Epidemiol. 24:230–239). Here we assess possible interaction between the child'sTGFATaqI A2A2 genotype and maternal cigarette smoking, alcohol consumption, use of multivitamins and folic acid. This was done by comparing the strength of genetic associations between strata of exposed and unexposed case‐parent triads. We also looked for possible gene‐gene interaction with the polymorphic variant C677T of the folic acid‐metabolizing geneMTHFR. We analyzed a total of 88 complete CPO triads selected from a population‐based study of orofacial clefts in Norway (May 1996–1998). No evidence of interaction was observed with either smoking or alcohol use. The risk associated with two copies of the A2 allele atTGFATaqI was strong among children whose mothers did not use folic acid (relative risk=4.5, 95% confidence interval=1.3–15.7), and was only marginal among children whose mothers reported using folic acid (RR=1.4, 95% CI=0.2–12.7). Although the interaction between the child's genotypes atTGFATaqI andMTHFR‐C677T was not statistically significant, the effect of theTGFATaqI A2A2 genotype appeared to be stronger among children with either one or two copies of the T‐allele at C677T (RR=4.0, 95% CI=1.1–13.9) compared to children homozygous for the C‐allele (RR=1.7, 95% CI=0.2–15.7). In conclusion, we find little evidence of interaction between the child's genotypes atTGFATaqI and various exposures for cleft palate, with the possible exception of folic acid intake.Genet Epidemiol25:367–374, 2003.
- Open Access
- 15 June 2003
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 157 (12) , 1083-1091
Exploring the Effects of Methylenetetrahydrofolate Reductase Gene Variants C677T and A1298C on the Risk of Orofacial Clefts in 261 Norwegian Case-Parent Triads
Folic acid and the methylenetetrahydrofolate reductase (MTHFR) gene have both been implicated in the etiology of orofacial clefts. The authors selected 261 case-parent triads (173 cases with cleft lip with or without cleft palate (CL/P) and 88 cases with cleft palate only (CPO)) from a Norwegian population-based study of orofacial clefts (May 1996–1998). A case-parent triad design was used to examine whether MTHFR variants C677T and A1298C, and their haplotypes, are risk factors for orofacial clefts. Among CL/P cases, the child’s genotype at C677T or A1298C did not influence the risk. However, children of mothers carrying the C677T variant allele had a lower risk of CL/P. For CPO, children carrying the C677T variant allele had about a twofold increased risk, whereas the mother’s genotypes did not contribute to the risk. The haplotype-based transmission/disequilibrium test showed that except for 677T/1298A (p = 0.06), none of the other haplotypes showed evidence of excess transmission to the offspring. The authors also explored interaction of C677T with maternal use of folic acid among children with CPO. Surprisingly, the risk associated with the child’s carrying either CT or TT was higher (fourfold) when the mother used folic acid. These findings suggest a possible role of MTHFR and folic acid in the causation of orofacial clefts, but the strength and direction of these effects remain to be clarified.
- 15 June 2003
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 157 (12) , 1083-1091
Open AccessExploring the Effects of Methylenetetrahydrofolate Reductase Gene Variants C677T and A1298C on the Risk of Orofacial Clefts in 261 Norwegian Case-Parent Triads
Folic acid and the methylenetetrahydrofolate reductase (MTHFR) gene have both been implicated in the etiology of orofacial clefts. The authors selected 261 case-parent triads (173 cases with cleft lip with or without cleft palate (CL/P) and 88 cases with cleft palate only (CPO)) from a Norwegian population-based study of orofacial clefts (May 1996–1998). A case-parent triad design was used to examine whether MTHFR variants C677T and A1298C, and their haplotypes, are risk factors for orofacial clefts. Among CL/P cases, the child’s genotype at C677T or A1298C did not influence the risk. However, children of mothers carrying the C677T variant allele had a lower risk of CL/P. For CPO, children carrying the C677T variant allele had about a twofold increased risk, whereas the mother’s genotypes did not contribute to the risk. The haplotype-based transmission/disequilibrium test showed that except for 677T/1298A (p = 0.06), none of the other haplotypes showed evidence of excess transmission to the offspring. The authors also explored interaction of C677T with maternal use of folic acid among children with CPO. Surprisingly, the risk associated with the child’s carrying either CT or TT was higher (fourfold) when the mother used folic acid. These findings suggest a possible role of MTHFR and folic acid in the causation of orofacial clefts, but the strength and direction of these effects remain to be clarified.
- 17 March 2003
- Published by Wiley in Genetic Epidemiology
- Vol. 24 (3) , 230-239
Variants of developmental genes (TGFA, TGFB3, and MSX1) and their associations with orofacial clefts: A case‐parent triad analysis
We selected 262 case‐parent triads from a population‐based study of orofacial clefts in Norway, and examined variants of developmental genes TGFA, TGFB3, and MSX1 in the etiology of orofacial clefts. One hundred seventy‐four triads of cleft lip cases (CL±P) and 88 triads of cleft palate only cases (CPO) were analyzed. There was little evidence for an association of any of these genes with CL±P. The strongest association was a 1.7‐fold risk with two copies of the TGFB3‐CA variant (95% CI=0.9–3.0). Among CPO cases, there was a 3‐fold risk with two copies of the TGFA TaqI A2 allele, and no increase with one copy. Assuming this to be a recessive effect, we estimated a 3.2‐fold risk among babies homozygous for the variant (95% CI=1.1–9.2). Furthermore, there was strong evidence of gene‐gene interaction. While there was only a weak association of the MSX1‐CA variant with CPO, the risk was 9.7‐fold (95% CI=2.9–32) among children homozygous for both the MSX1‐CA A4 allele and the TGFA A2 allele. No association of CPO with the TGFA variant was seen among the other MSX1‐CA genotypes. In conclusion, no strong associations were found between CL±P and variants at these three genes. There was a possible recessive effect of the TGFA TaqI variant on the risk of CPO, with a 3‐fold risk among children homozygous for the variant. The effect of this TGFA genotype was even stronger among children homozygous for the MSX1‐CA A4 allele, raising the possibility of interaction between these two genes. Genet Epidemiol 24:230–239, 2003.
- 17 March 2003
- Published by Wiley in Genetic Epidemiology
- Vol. 24 (3) , 230-239
Variants of developmental genes (TGFA, TGFB3, and MSX1) and their associations with orofacial clefts: A case‐parent triad analysis
We selected 262 case‐parent triads from a population‐based study of orofacial clefts in Norway, and examined variants of developmental genes TGFA, TGFB3, and MSX1 in the etiology of orofacial clefts. One hundred seventy‐four triads of cleft lip cases (CL±P) and 88 triads of cleft palate only cases (CPO) were analyzed. There was little evidence for an association of any of these genes with CL±P. The strongest association was a 1.7‐fold risk with two copies of the TGFB3‐CA variant (95% CI=0.9–3.0). Among CPO cases, there was a 3‐fold risk with two copies of the TGFA TaqI A2 allele, and no increase with one copy. Assuming this to be a recessive effect, we estimated a 3.2‐fold risk among babies homozygous for the variant (95% CI=1.1–9.2). Furthermore, there was strong evidence of gene‐gene interaction. While there was only a weak association of the MSX1‐CA variant with CPO, the risk was 9.7‐fold (95% CI=2.9–32) among children homozygous for both the MSX1‐CA A4 allele and the TGFA A2 allele. No association of CPO with the TGFA variant was seen among the other MSX1‐CA genotypes. In conclusion, no strong associations were found between CL±P and variants at these three genes. There was a possible recessive effect of the TGFA TaqI variant on the risk of CPO, with a 3‐fold risk among children homozygous for the variant. The effect of this TGFA genotype was even stronger among children homozygous for the MSX1‐CA A4 allele, raising the possibility of interaction between these two genes. Genet Epidemiol 24:230–239, 2003.